Tag: Progress in Alzheimer’s treatment
New Title: FDA Advisory Panel Approves Experimental Alzheimer’s Drug: Promising Progress Ahead
An experimental Alzheimer’s drug called donanemab received approval from a U.S. Food and Drug Administration advisory panel. The drug is intended to treat early...
BREAKING NEWS
Top Supreme Court Rulings of 2024: Presidential Immunity & Chevron Doctrine
Supreme Court Rulings of 2024: A Year of Legal LandmarksIn a year of tense legal battles and high-stakes decisions, the U.S. Supreme Court has...
